Histological transformation of MALT lymphoma to plasma cell leukemia after rituximab-containing therapy

Ann Hematol. 2018 Jul;97(7):1297-1298. doi: 10.1007/s00277-018-3300-2. Epub 2018 Mar 26.

Authors

Yutaro Suzuki¹, Akira Honda¹, Kumi Nakazaki¹, Hideaki Mizuno¹, Masako Ikemura², Aya Shinozaki-Ushiku², Fumihiko Nakamura¹, Masashi Fukayama², Mineo Kurokawa³

Affiliations

¹ Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
² Department of Pathology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
³ Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. [email protected].

PMID: 29582109
DOI: 10.1007/s00277-018-3300-2

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Female
Humans
Leukemia, Plasma Cell / chemically induced*
Leukemia, Plasma Cell / metabolism
Leukemia, Plasma Cell / pathology
Lymphoma, B-Cell, Marginal Zone / drug therapy*
Lymphoma, B-Cell, Marginal Zone / metabolism
Lymphoma, B-Cell, Marginal Zone / pathology
Rituximab / administration & dosage
Rituximab / adverse effects*

Substances

Rituximab